Quarterly Statement Of Cash Flows

TORII PHARMACEUTICAL CO., LTD. - Filing #7271627

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
4,795,000,000 JPY
-1,780,000,000 JPY
Interest and dividends received
540,000,000 JPY
460,000,000 JPY
Interest paid
0 JPY
0 JPY
Net cash provided by (used in) operating activities
3,639,000,000 JPY
-3,123,000,000 JPY
Cash flows from investing activities
Purchase of securities
-10,007,000,000 JPY
-9,001,000,000 JPY
Purchase of property, plant and equipment
-152,000,000 JPY
-162,000,000 JPY
Proceeds from sale of property, plant and equipment
JPY
0 JPY
Purchase of investment securities
-21,065,000,000 JPY
-17,588,000,000 JPY
Other, net
-1,817,000,000 JPY
JPY
Net cash provided by (used in) investing activities
-3,571,000,000 JPY
-3,779,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-2,000,000 JPY
0 JPY
Dividends paid
-3,654,000,000 JPY
-3,540,000,000 JPY
Net cash provided by (used in) financing activities
-3,944,000,000 JPY
-3,835,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-3,876,000,000 JPY
-10,738,000,000 JPY
Cash and cash equivalents
30,805,000,000 JPY
34,681,000,000 JPY
45,420,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.